THE global leader in  blood management solutions for our customers

Quarterly Earnings

CategoryDateTitle
Q1 2015 Earnings07/30/14
Haemonetics Reports 1st Quarter Fiscal 2015 Revenue of $224 Million and Adjusted EPS of $0.38, Affirms Full Fiscal Year Guidance
Q4 2014 Earnings04/28/14
Haemonetics Reports 4th Quarter Fiscal 2014 Revenue of $241 Million and Adjusted EPS of $0.46; Full Year Revenue of $939 Million, Up 5% and Adjusted EPS of $2.19, Up 10%
Q3 2014 Earnings01/27/14
Haemonetics Reports 3rd Quarter Fiscal 2014 Revenue of $242 Million and $0.61 Adjusted EPS; Extends Multi-Year Agreements With Key Plasma Customers
Q2 2014 Earnings10/28/13
Haemonetics Reports 2nd Quarter Fiscal 2014 Revenue Up 8%; Adjusted Operating Margin Up 260 Basis Points; and $0.66 Adjusted EPS Up 24%
Q1 2014 Earnings07/29/13
Haemonetics Reports 1st Quarter Fiscal 2014 Revenue Up 24%; Adjusted EPS of $0.46 Up 46%; Adjusted Operating Margin Improvement of 270 Basis Points; and Significant Progress on Planned Manufacturing Transformation
Q4 2013 Earnings05/01/13
Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance
Q3 2013 Earnings01/30/13
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
Q2 2013 Earnings10/29/12
Haemonetics Reports Second Quarter Fiscal 2013 Revenue Up 22%, Organic Revenue Up 6% and Adjusted EPS of $0.90, Reaffirms Fiscal 2013 Guidance and Announces Two-For-One Stock Split
Q1 2013 Earnings08/01/12
Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Pall's Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
Q4 2012 Earnings04/29/12
Haemonetics Reports 10% Revenue Growth for Fourth Quarter of Fiscal 2012 and $0.80 Adjusted EPS; Also Establishes Fiscal 2013 Guidance
Q3 2012 Earnings01/30/12
Haemonetics Reports 8% Revenue Growth for Third Quarter of Fiscal 2012 and $0.86 Adjusted EPS; Announces Multi-Year Contract Extensions With Key Plasma Collection Customers; And Affirms Fiscal 2012 Guidance
Q2 2012 Earnings10/31/11
Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
Q1 2012 Earnings08/01/11
Haemonetics Reports 5% Revenue Growth for First Quarter Fiscal 2012, Earnings per Share of $0.65 and Revised Annual Earnings Guidance of $3.35-$3.45, Impacted by the OrthoPAT® Recall
Q4 2011 Earnings05/02/11
Haemonetics Reports 15% Growth in Adjusted EPS to $3.27 for Fiscal 2011
Q3 2011 Earnings01/31/11
Haemonetics Reports Third Quarter of Fiscal 11
Q2 2011 Earnings11/01/10
Haemonetics Reports Adjusted Earnings per Share of $0.80 for Q2 of Fiscal 11
Q1 2011 Earnings08/02/10
Haemonetics Reports Adjusted Earnings per Share of $0.74 for Q1 of Fiscal 11 Company Affirms Full Year Guidance
Q4 2010 Earnings05/04/10
Haemonetics Reports Double Digit Growth in Adjusted EPS of $2.85 for Fiscal 2010; Issues Guidance for Continued, Strong Growth in Fiscal 2011
Q3 2010 Earnings02/01/10
Haemonetics Reports Double Digit Growth in Earnings Per Share for Third Quarter Fiscal 2010
Q2 2010 Earnings11/02/09
Haemonetics Reports Double Digit Growth in Earnings for Second Quarter Fiscal 2010
Q1 2010 Earnings08/03/09
Haemonetics Reports Double Digit Growth in Earnings for First Quarter Fiscal 2010
Q4 2009 Earnings05/04/09
Haemonetics Reports Strong Double Digit Growth in Revenue, Net Income, and EPS for Fiscal 2009 and Issues Guidance for Continued, Strong Growth in Fiscal 2010
Q3 2009 Earnings02/02/09
Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
Q2 2009 Earnings10/27/08
Haemonetics Reports Double Digit Revenue, Operating Income, and EPS Growth for the Second Quarter Fiscal 2009
Q1 2009 Earnings08/01/08
Haemonetics Reports Double Digit Revenue, Operating Income, and EPS Growth for the First Quarter Fiscal 2009
Get help downloading or viewing the above file types